2-147927213-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001616.5(ACVR2A):āc.1481T>Cā(p.Ile494Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,612,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000079 ( 0 hom., cov: 32)
Exomes š: 0.000021 ( 0 hom. )
Consequence
ACVR2A
NM_001616.5 missense
NM_001616.5 missense
Scores
2
5
12
Clinical Significance
Conservation
PhyloP100: 7.67
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.23974738).
BS2
High AC in GnomAd4 at 12 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACVR2A | NM_001616.5 | c.1481T>C | p.Ile494Thr | missense_variant | 11/11 | ENST00000241416.12 | NP_001607.1 | |
ACVR2A | NM_001278579.2 | c.1481T>C | p.Ile494Thr | missense_variant | 12/12 | NP_001265508.1 | ||
ACVR2A | NM_001278580.2 | c.1157T>C | p.Ile386Thr | missense_variant | 11/11 | NP_001265509.1 | ||
ACVR2A | XM_047446292.1 | c.1157T>C | p.Ile386Thr | missense_variant | 11/11 | XP_047302248.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACVR2A | ENST00000241416.12 | c.1481T>C | p.Ile494Thr | missense_variant | 11/11 | 1 | NM_001616.5 | ENSP00000241416 | P1 | |
ACVR2A | ENST00000404590.1 | c.1481T>C | p.Ile494Thr | missense_variant | 12/12 | 1 | ENSP00000384338 | P1 | ||
ACVR2A | ENST00000535787.5 | c.1157T>C | p.Ile386Thr | missense_variant | 11/11 | 2 | ENSP00000439988 | |||
ACVR2A | ENST00000495775.1 | n.609T>C | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151902Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
12
AN:
151902
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000680 AC: 17AN: 249906Hom.: 0 AF XY: 0.0000814 AC XY: 11AN XY: 135054
GnomAD3 exomes
AF:
AC:
17
AN:
249906
Hom.:
AF XY:
AC XY:
11
AN XY:
135054
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1460180Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 726384
GnomAD4 exome
AF:
AC:
30
AN:
1460180
Hom.:
Cov.:
31
AF XY:
AC XY:
17
AN XY:
726384
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151902Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74190
GnomAD4 genome
AF:
AC:
12
AN:
151902
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2023 | The c.1481T>C (p.I494T) alteration is located in exon 11 (coding exon 11) of the ACVR2A gene. This alteration results from a T to C substitution at nucleotide position 1481, causing the isoleucine (I) at amino acid position 494 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;L
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;.;B
Vest4
MutPred
Gain of sheet (P = 0.0221);.;Gain of sheet (P = 0.0221);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at